Table of Contents
Pharmacy technicians play a crucial role in the management of patients on SGLT2 inhibitors, a class of medications used primarily for type 2 diabetes. Understanding the key monitoring parameters ensures patient safety and optimal therapeutic outcomes.
What Are SGLT2 Inhibitors?
SGLT2 inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, work by blocking the sodium-glucose co-transporter 2 in the kidneys. This action reduces glucose reabsorption, leading to increased urinary glucose excretion and lowered blood glucose levels.
Key Monitoring Parameters
Blood Glucose Levels
Regular monitoring of blood glucose helps assess the effectiveness of therapy and guides adjustments. Educate patients on self-monitoring and ensure lab tests are up to date.
Renal Function
SGLT2 inhibitors can impact kidney function. Monitoring serum creatinine and estimated glomerular filtration rate (eGFR) before initiation and periodically thereafter is essential. Be alert for signs of dehydration or acute kidney injury.
Electrolytes
Electrolyte imbalances, particularly sodium and potassium, should be monitored, especially in patients with compromised renal function or those on diuretics.
Recognizing Adverse Effects
Pharmacy technicians should be aware of common adverse effects linked to SGLT2 inhibitors, including urinary tract infections, genital mycotic infections, and dehydration. Prompt reporting to healthcare providers is vital.
Patient Education Tips
Educate patients on maintaining hydration, recognizing signs of infections, and adhering to prescribed monitoring schedules. Emphasize the importance of reporting symptoms such as dizziness, excessive thirst, or urinary discomfort.
Conclusion
Effective monitoring of patients on SGLT2 inhibitors is a team effort. Pharmacy technicians are vital in ensuring compliance, recognizing adverse effects, and facilitating communication between patients and healthcare providers for safe and effective therapy.